HemOnc Today scans the TOP 30 JOURNALS to bring you the most important articles published in your field.
 Personalize your search
In the Journals Plus

End-of-life care 'suboptimal' in elderly patients with acute myeloid leukemia

Wang R, et al. J Clin Oncol. 2017;doi:10.1200/JCO.2017.72.7149.
End-of-life care suboptimal for elderly patients with acute myeloid leukemia, with increas use of hospice care occurring mostly in the last 7 days of…
In the Journals Plus

Ipatasertib shows promise for triple-negative breast cancer

Delaloge S and DeForceville L. Lancet Oncol. 2017;doi:10.1016/S1470-2045(17)30450-3.
Kim SB, et al. Lancet Oncol. 2017;doi:10.1016/S1470-2045(17)30450-3.
The addition of ipatasertib to paclitaxel improved PFS among women with triple-negative breast cancer, according to results from the LOTUS trial…
In the Journals Plus

Melanoma immunotherapy trials may not capture all toxicity data

Shoushtari AN, et al. JAMA Oncol. 2017;doi:10.1001/jamaoncol.2017.2391.
Common Terminology Criteria for Adverse Events may not appropriately reflect immune-related adverse event severity, duration or timing, according to…
In the Journals Plus

HPV behind nearly 75% of oropharyngeal cancer cases in Canada

Habbous S, et al. CMAJ. 2017;doi:10.1503/cmaj.161379.
The proportion of oropharyngeal cancers associated with HPV in several cancer centers across Canada rose from nearly half to nearly three-quarters…
In the Journals Plus

Fusions define new colorectal cancer subtype with poor prognosis

Pietrantonio F, et al. JNCI J Natl Cancer Inst. 2017;doi:10.1093/jnci/djx089.
Patients with ALK-, ROS1- or NTRK-rearranged tumors defined a rare subtype in metastatic colorectal cancer associated with poor outcomes, according…
In the Journals Plus

Vorinostat may prevent graft-versus-host disease after unrelated donor bone marrow transplant

Choi SW, et al. Blood. 2017;doi:10.1182/blood-2017-06-790469.
Vorinostat appeared safe and effective combined with standard graft-versus-host disease prophylaxis for patients undergoing matched unrelated donor…
In the Journals Plus

CAR T-cell therapy effective for chronic lymphocytic leukemia

Turtle CJ, et al. J Clin Oncol. 2017;doi:10.1200/JCO.2017.72.8519.
CD19-specific chimeric antigen receptor-modified T-cell therapy induced durable molecular remissions in patients with high-risk chronic lymphocytic…
In the Journals Plus

Liquid biopsy offers option for EGFR testing without lung tumor tissue

Mayo-de-las-Casas C, et al. Ann Oncol. 2017;doi:10.1093/annonc/mdx288.
Blood assays identified EGFR mutations in patients with advanced non-small cell lung cancer with insufficient tumor biopsies, according to a…
In the Journals Plus

Older patients with cancer may burden caregivers by overestimating physical abilities

Hsu T, et al. Oncologist. 2017;doi:10.1634/theoncologist.2017-0085.
Older patients with cancer often reported having better physical function, mental health and social support than their caregivers’ assessments…
In the Journals Plus

ASCO updates guideline on systemic therapy for non-small cell lung cancer

Hanna N, et al. J Clin Oncol. 2017;doi:10.1200/JCO.2017.74.6065.  
An updated ASCO clinical practice guideline clarifies the appropriate use of immunotherapy and provides new recommendations on the use of targeted…
In the Journals Plus

Adolescents who distrust cancer care for a dying parent likely to face psychological problems

Beernaert K, et al. J Clin Oncol. 2017;doi:10.1200/JCO.2017.72.9814.
Adults who did not trust health care professionals after losing a parent to cancer during adolescence had a higher risk for negative long-term…
In the Journals Plus

Venous thromboembolic events persist despite in-hospital prophylaxis

Heit JA, et al. Blood. 2017.doi:10.1182/blood-2016-12-758995.
Near-universal in-hospital prophylaxis did not lead to declines in hospital-related venous thromboembolic events, according to a study published in…
In the Journals Plus

HER-2 mutation found in advanced lung cancer

Pillai RN, et al. Cancer. 2017;doi:10.1002/cncr.30869.
Nearly 3% of patients with advanced lung adenocarcinoma tested positive for the HER-2 gene, the common driver mutation for breast cancer, according…
In the Journals Plus

Low-risk thyroid cancer may respond to less aggressive treatments

Robenshtok E, et al. Thyroid. 2017;doi:10.1089/thy.2017.0040.
Adults with low-risk differentiated thyroid cancer may be at lower risk for disease-related mortality compared with those with intermediate- and…
In the Journals PlusPerspective

Breast cancer outcomes for young women who choose conservative treatment improve over time

Botteri E, et al. Br J Surg. 2017;doi:10.1002/bjs.10658.
Outcomes for young women with breast cancer who underwent conservative treatment improved significantly over time, according to results of a…
Advertisement
Advertisement

Personalize your search

to